Showing results (181-190 of 202) with videos related to
Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2009
HDAC6 is a target for protection and regeneration following injury in the nervous systemMark A Rivieccio, Camille Brochier, Dianna E Willis, et al.Experimental Neurology|March 10, 2020
HDAC6 inhibition promotes α-tubulin acetylation and ameliorates CMT2A peripheral neuropathy in miceCristina Picci, Victor S C Wong, Christopher J Costa, et al.The Journal of Clinical Investigation|November 13, 2013
A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomasTint Lwin, Xiaohong Zhao, Fengdong Cheng, et al.International Journal of Molecular Sciences|May 1, 2019
Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of CancerAmreena Suri, Anders W Bailey, Maurício T Tavares, et al.Journal of Medicinal Chemistry|September 13, 2011
Discovery of isoxazole analogues of sazetidine-A as selective α4β2-nicotinic acetylcholine receptor partial agonists for the treatment of depressionJianhua Liu, Li-Fang Yu, J Brek Eaton, et al.Journal of Medicinal Chemistry|April 8, 2021
Tetrahydroquinoline-Capped Histone Deacetylase 6 Inhibitor SW-101 Ameliorates Pathological Phenotypes in a Charcot-Marie-Tooth Type 2A Mouse ModelSida Shen, Cristina Picci, Kseniya Ustinova, et al.Journal of Medicinal Chemistry|January 31, 2015
Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agentsJianjun Cheng, Patrick M Giguère, Oluseye K Onajole, et al.ACS Chemical Neuroscience|December 5, 2018
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X SyndromeAlan P Kozikowski, Sida Shen, Marta Pardo, et al.Pharmacology Research & Perspectives|December 16, 2014
The potent and selective α4β2*/α6*-nicotinic acetylcholine receptor partial agonist 2-[5-[5-((S)Azetidin-2-ylmethoxy)-3-pyridinyl]-3-isoxazolyl]ethanol demonstrates antidepressive-like behavior in animal models and a favorable ADME-tox profileLi-Fang Yu, J Brek Eaton, Han-Kun Zhang, et al.Brain : a Journal of Neurology|February 8, 2018
HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth diseaseVeronick Benoy, Lawrence Van Helleputte, Robert Prior, et al.Pageof 21